ABBV logo

AbbVie (ABBV) Working Capital

Annual Working Capital

-$13.17 B
-$8.33 B-172.10%

December 1, 2024


Summary


Performance

ABBV Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABBVbalance sheetmetrics:

Quarterly Working Capital

N/A

December 1, 2024


Summary


Performance

ABBV Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherABBVbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

ABBV Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-172.1%-
3 y3 years-81.2%-
5 y5 years-138.8%-

ABBV Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-1124.8%at low
5 y5-year-138.8%at low
alltimeall time-138.8%at low

AbbVie Working Capital History

DateAnnualQuarterly
Dec 2024
-$13.17 B(+172.1%)
-
Sep 2024
-
-$15.28 B(+88.6%)
Jun 2024
-
-$8.10 B(+205.5%)
Mar 2024
-
-$2.65 B(-45.2%)
Dec 2023
-$4.84 B(+350.1%)
-$4.84 B(+212.4%)
Sep 2023
-
-$1.55 B(-54.3%)
Jun 2023
-
-$3.39 B(+207.4%)
Mar 2023
-
-$1.10 B(+2.5%)
Dec 2022
-$1.07 B(-85.2%)
-$1.07 B(-54.2%)
Sep 2022
-
-$2.35 B(-56.3%)
Jun 2022
-
-$5.37 B(-10.6%)
Mar 2022
-
-$6.01 B(-17.3%)
Dec 2021
-$7.27 B(+61.9%)
-$7.27 B(-1813.7%)
Sep 2021
-
$424.00 M(-115.8%)
Jun 2021
-
-$2.69 B(-50.1%)
Mar 2021
-
-$5.38 B(+19.9%)
Dec 2020
-$4.49 B(-113.2%)
-$4.49 B(+282.9%)
Sep 2020
-
-$1.17 B(-65.4%)
Jun 2020
-
-$3.39 B(-109.6%)
Mar 2020
-
$35.29 B(+4.0%)
Dec 2019
$33.93 B(<-9900.0%)
$33.93 B(+1169.5%)
Sep 2019
-
$2.67 B(-245.2%)
Jun 2019
-
-$1.84 B(-461.7%)
Mar 2019
-
$509.00 M(-273.1%)
Dec 2018
-$294.00 M
-$294.00 M(-109.6%)
Sep 2018
-
$3.08 B(-191.1%)
Jun 2018
-
-$3.38 B(-199.8%)
DateAnnualQuarterly
Mar 2018
-
$3.39 B(-26.1%)
Dec 2017
$4.58 B(-28.5%)
$4.58 B(-22.3%)
Sep 2017
-
$5.90 B(+25.4%)
Jun 2017
-
$4.70 B(-29.8%)
Mar 2017
-
$6.70 B(+4.6%)
Dec 2016
$6.41 B(+18.2%)
$6.41 B(-10.9%)
Sep 2016
-
$7.19 B(-4.4%)
Jun 2016
-
$7.52 B(+26.2%)
Mar 2016
-
$5.96 B(+10.0%)
Dec 2015
$5.42 B(+15.6%)
$5.42 B(-40.4%)
Sep 2015
-
$9.10 B(+61.9%)
Jun 2015
-
$5.62 B(+28.9%)
Mar 2015
-
$4.36 B(-7.0%)
Dec 2014
$4.69 B(-57.3%)
$4.69 B(-57.1%)
Sep 2014
-
$10.92 B(-4.9%)
Jun 2014
-
$11.48 B(+3.3%)
Mar 2014
-
$11.11 B(+1.3%)
Dec 2013
$10.97 B(+27.9%)
$10.97 B(+13.5%)
Sep 2013
-
$9.67 B(+9.2%)
Jun 2013
-
$8.86 B(+8.6%)
Mar 2013
-
$8.16 B(-4.9%)
Dec 2012
$8.58 B(+488.7%)
$8.58 B(+54.2%)
Sep 2012
-
$5.56 B(+382.4%)
Jun 2012
-
$1.15 B(-6.7%)
Mar 2012
-
$1.24 B(-15.2%)
Dec 2011
$1.46 B(-67.3%)
$1.46 B
Dec 2010
$4.46 B
-

FAQ

  • What is AbbVie annual working capital?
  • What is the all time high annual working capital for AbbVie?
  • What is AbbVie annual working capital year-on-year change?
  • What is the all time high quarterly working capital for AbbVie?

What is AbbVie annual working capital?

The current annual working capital of ABBV is -$13.17 B

What is the all time high annual working capital for AbbVie?

AbbVie all-time high annual working capital is $33.93 B

What is AbbVie annual working capital year-on-year change?

Over the past year, ABBV annual working capital has changed by -$8.33 B (-172.10%)

What is the all time high quarterly working capital for AbbVie?

AbbVie all-time high quarterly working capital is $35.29 B